ALLIANCEBERNSTEIN L.P. - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 189 filers reported holding HERON THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 1.56 and the average weighting 0.2%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$694,925
+52.0%
198,550
+20.3%
0.00%
Q1 2024$457,133
+38.9%
165,030
-14.8%
0.00%
Q4 2023$329,154
+65.0%
193,6200.0%0.00%
Q3 2023$199,429
-11.2%
193,6200.0%0.00%
Q2 2023$224,599
-15.9%
193,620
+9.5%
0.00%
Q1 2023$267,119
-39.6%
176,9000.0%0.00%
Q4 2022$442,250
-34.9%
176,900
+10.0%
0.00%
Q3 2022$679,000
+51.2%
160,8000.0%0.00%
Q2 2022$449,000
-79.3%
160,800
-57.6%
0.00%
-100.0%
Q1 2022$2,170,000
+84.2%
379,300
+194.0%
0.00%
Q4 2021$1,178,000
-23.0%
129,000
-9.9%
0.00%
-100.0%
Q3 2021$1,530,000
-31.1%
143,1000.0%0.00%0.0%
Q2 2021$2,221,000
-31.8%
143,100
-28.8%
0.00%0.0%
Q1 2021$3,256,000
-23.4%
200,8520.0%0.00%
-50.0%
Q4 2020$4,251,000
+42.8%
200,8520.0%0.00%0.0%
Q3 2020$2,977,000
-25.5%
200,852
-26.1%
0.00%0.0%
Q2 2020$3,996,000
+30.6%
271,630
+4.2%
0.00%0.0%
Q1 2020$3,060,000
+3.7%
260,630
+107.5%
0.00%0.0%
Q4 2019$2,952,000
+30.3%
125,600
+2.5%
0.00%
+100.0%
Q3 2019$2,266,000
-0.5%
122,5000.0%0.00%0.0%
Q2 2019$2,277,000
-41.7%
122,500
-23.3%
0.00%
-66.7%
Q1 2019$3,903,000
+45.8%
159,693
+54.7%
0.00%
+50.0%
Q4 2018$2,677,000
-18.0%
103,2000.0%0.00%0.0%
Q3 2018$3,266,000
-18.5%
103,2000.0%0.00%
-33.3%
Q2 2018$4,009,000
+158.0%
103,200
+83.3%
0.00%
+200.0%
Q1 2018$1,554,000
-22.6%
56,300
-49.2%
0.00%0.0%
Q4 2017$2,007,000
+88.8%
110,900
+68.5%
0.00%0.0%
Q3 2017$1,063,000
+16.7%
65,8000.0%0.00%0.0%
Q2 2017$911,000
+9.0%
65,800
+18.1%
0.00%0.0%
Q1 2017$836,000
+31.0%
55,700
+14.4%
0.00%0.0%
Q4 2016$638,000
-24.0%
48,7000.0%0.00%0.0%
Q3 2016$839,000
-2.0%
48,700
+2.7%
0.00%0.0%
Q2 2016$856,000
-4.9%
47,4000.0%0.00%0.0%
Q1 2016$900,000
-94.7%
47,400
-92.5%
0.00%
-92.9%
Q4 2015$16,937,000
+14.3%
634,361
+4.4%
0.01%
+7.7%
Q3 2015$14,823,000
+903.6%
607,487
+1181.6%
0.01%
+1200.0%
Q2 2015$1,477,000
+2585.5%
47,400
+1147.4%
0.00%
Q1 2015$55,000
+450.0%
3,800
+280.0%
0.00%
Q4 2014$10,000
+25.0%
1,0000.0%0.00%
Q3 2014$8,000
-68.0%
1,000
-50.0%
0.00%
Q2 2014$25,0002,0000.00%
Other shareholders
HERON THERAPEUTICS INC shareholders Q2 2024
NameSharesValueWeighting ↓
TANG KEVIN 37,999$706,00024.13%
TANG CAPITAL MANAGEMENT LLC 5,744,096$106,783,00014.43%
BRIDGER MANAGEMENT, LLC 2,846,555$52,917,0004.15%
First Light Asset Management, LLC 1,098,723$20,425,0002.84%
Broadfin Capital, LLC 657,998$12,232,0002.66%
HIGHLAND CAPITAL MANAGEMENT LP 1,606,942$29,873,0001.75%
EMORY UNIVERSITY 129,020$2,398,0001.69%
Mesirow Financial Investment Management, Inc. 24,112$430,0001.57%
Congress Park Capital LLC 109,665$1,945,0001.54%
KINGDON CAPITAL MANAGEMENT, L.L.C. 830,821$15,445,0001.52%
View complete list of HERON THERAPEUTICS INC shareholders